Nrf2 protects human bladder urothelial cells from arsenite and monomethylarsonous acid toxicity

Xiao Jun Wang, Zheng Sun, Weimin Chen, Kylee E. Eblin, A Jay Gandolfi, Donna Zhang

Research output: Contribution to journalArticle

86 Citations (Scopus)

Abstract

Arsenic is widely spread in our living environment and imposes a big challenge on human health worldwide. Arsenic damages biological systems through multiple mechanisms including the generation of reactive oxygen species. The transcription factor Nrf2 regulates the cellular antioxidant response that protects cells from various insults. In this study, the protective role of Nrf2 in arsenic toxicity was investigated in a human bladder urothelial cell line, UROtsa. Using a UROtsa cell line stably infected with Nrf2-siRNA, we clearly demonstrate that compromised Nrf2 expression sensitized the cells to As(III)- and MMA(III)-induced toxicity. On the other hand, the activation of the Nrf2 pathway by tert-butylhydroquinone (tBHQ) and sulforaphane (SF), the known Nrf2-inducers, rendered UROtsa cells more resistant to As(III) and MMA(III). Furthermore, the wild-type mouse embryo fibroblast (WT-MEF) cells were protected from As(III)- and MMA(III)-induced toxicity following Nrf2 activation by tBHQ or SF, whereas neither tBHQ nor SF conferred protection in the Nrf2-/-MEF cells, demonstrating that tBHQ- or SF-mediated protection against As(III)- and MMA(III)-induced toxicity depends on Nrf2 activation. These results, obtained by both loss of function and gain of function analyses, clearly demonstrate the protective role of Nrf2 in arsenic-induced toxicity. The current work lays the groundwork for using Nrf2 activators for therapeutic and dietary interventions against adverse effects of arsenic.

Original languageEnglish (US)
Pages (from-to)206-213
Number of pages8
JournalToxicology and Applied Pharmacology
Volume225
Issue number2
DOIs
StatePublished - Dec 1 2007

Fingerprint

Arsenic
Toxicity
Urinary Bladder
Chemical activation
Cells
Cell Line
Biological systems
Fibroblasts
Small Interfering RNA
Reactive Oxygen Species
Transcription Factors
Embryonic Structures
Antioxidants
arsenite
monomethylarsonous acid
Health
2-tert-butylhydroquinone
sulforafan

Keywords

  • Arsenic
  • Arsenite
  • Keap1
  • MMA(III)
  • Nrf2
  • UROtsa

ASJC Scopus subject areas

  • Pharmacology
  • Toxicology

Cite this

Nrf2 protects human bladder urothelial cells from arsenite and monomethylarsonous acid toxicity. / Wang, Xiao Jun; Sun, Zheng; Chen, Weimin; Eblin, Kylee E.; Gandolfi, A Jay; Zhang, Donna.

In: Toxicology and Applied Pharmacology, Vol. 225, No. 2, 01.12.2007, p. 206-213.

Research output: Contribution to journalArticle

@article{63ddc8d539eb4e1e9f73fb839e6df072,
title = "Nrf2 protects human bladder urothelial cells from arsenite and monomethylarsonous acid toxicity",
abstract = "Arsenic is widely spread in our living environment and imposes a big challenge on human health worldwide. Arsenic damages biological systems through multiple mechanisms including the generation of reactive oxygen species. The transcription factor Nrf2 regulates the cellular antioxidant response that protects cells from various insults. In this study, the protective role of Nrf2 in arsenic toxicity was investigated in a human bladder urothelial cell line, UROtsa. Using a UROtsa cell line stably infected with Nrf2-siRNA, we clearly demonstrate that compromised Nrf2 expression sensitized the cells to As(III)- and MMA(III)-induced toxicity. On the other hand, the activation of the Nrf2 pathway by tert-butylhydroquinone (tBHQ) and sulforaphane (SF), the known Nrf2-inducers, rendered UROtsa cells more resistant to As(III) and MMA(III). Furthermore, the wild-type mouse embryo fibroblast (WT-MEF) cells were protected from As(III)- and MMA(III)-induced toxicity following Nrf2 activation by tBHQ or SF, whereas neither tBHQ nor SF conferred protection in the Nrf2-/-MEF cells, demonstrating that tBHQ- or SF-mediated protection against As(III)- and MMA(III)-induced toxicity depends on Nrf2 activation. These results, obtained by both loss of function and gain of function analyses, clearly demonstrate the protective role of Nrf2 in arsenic-induced toxicity. The current work lays the groundwork for using Nrf2 activators for therapeutic and dietary interventions against adverse effects of arsenic.",
keywords = "Arsenic, Arsenite, Keap1, MMA(III), Nrf2, UROtsa",
author = "Wang, {Xiao Jun} and Zheng Sun and Weimin Chen and Eblin, {Kylee E.} and Gandolfi, {A Jay} and Donna Zhang",
year = "2007",
month = "12",
day = "1",
doi = "10.1016/j.taap.2007.07.016",
language = "English (US)",
volume = "225",
pages = "206--213",
journal = "Toxicology and Applied Pharmacology",
issn = "0041-008X",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - Nrf2 protects human bladder urothelial cells from arsenite and monomethylarsonous acid toxicity

AU - Wang, Xiao Jun

AU - Sun, Zheng

AU - Chen, Weimin

AU - Eblin, Kylee E.

AU - Gandolfi, A Jay

AU - Zhang, Donna

PY - 2007/12/1

Y1 - 2007/12/1

N2 - Arsenic is widely spread in our living environment and imposes a big challenge on human health worldwide. Arsenic damages biological systems through multiple mechanisms including the generation of reactive oxygen species. The transcription factor Nrf2 regulates the cellular antioxidant response that protects cells from various insults. In this study, the protective role of Nrf2 in arsenic toxicity was investigated in a human bladder urothelial cell line, UROtsa. Using a UROtsa cell line stably infected with Nrf2-siRNA, we clearly demonstrate that compromised Nrf2 expression sensitized the cells to As(III)- and MMA(III)-induced toxicity. On the other hand, the activation of the Nrf2 pathway by tert-butylhydroquinone (tBHQ) and sulforaphane (SF), the known Nrf2-inducers, rendered UROtsa cells more resistant to As(III) and MMA(III). Furthermore, the wild-type mouse embryo fibroblast (WT-MEF) cells were protected from As(III)- and MMA(III)-induced toxicity following Nrf2 activation by tBHQ or SF, whereas neither tBHQ nor SF conferred protection in the Nrf2-/-MEF cells, demonstrating that tBHQ- or SF-mediated protection against As(III)- and MMA(III)-induced toxicity depends on Nrf2 activation. These results, obtained by both loss of function and gain of function analyses, clearly demonstrate the protective role of Nrf2 in arsenic-induced toxicity. The current work lays the groundwork for using Nrf2 activators for therapeutic and dietary interventions against adverse effects of arsenic.

AB - Arsenic is widely spread in our living environment and imposes a big challenge on human health worldwide. Arsenic damages biological systems through multiple mechanisms including the generation of reactive oxygen species. The transcription factor Nrf2 regulates the cellular antioxidant response that protects cells from various insults. In this study, the protective role of Nrf2 in arsenic toxicity was investigated in a human bladder urothelial cell line, UROtsa. Using a UROtsa cell line stably infected with Nrf2-siRNA, we clearly demonstrate that compromised Nrf2 expression sensitized the cells to As(III)- and MMA(III)-induced toxicity. On the other hand, the activation of the Nrf2 pathway by tert-butylhydroquinone (tBHQ) and sulforaphane (SF), the known Nrf2-inducers, rendered UROtsa cells more resistant to As(III) and MMA(III). Furthermore, the wild-type mouse embryo fibroblast (WT-MEF) cells were protected from As(III)- and MMA(III)-induced toxicity following Nrf2 activation by tBHQ or SF, whereas neither tBHQ nor SF conferred protection in the Nrf2-/-MEF cells, demonstrating that tBHQ- or SF-mediated protection against As(III)- and MMA(III)-induced toxicity depends on Nrf2 activation. These results, obtained by both loss of function and gain of function analyses, clearly demonstrate the protective role of Nrf2 in arsenic-induced toxicity. The current work lays the groundwork for using Nrf2 activators for therapeutic and dietary interventions against adverse effects of arsenic.

KW - Arsenic

KW - Arsenite

KW - Keap1

KW - MMA(III)

KW - Nrf2

KW - UROtsa

UR - http://www.scopus.com/inward/record.url?scp=36049010730&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=36049010730&partnerID=8YFLogxK

U2 - 10.1016/j.taap.2007.07.016

DO - 10.1016/j.taap.2007.07.016

M3 - Article

C2 - 17765279

AN - SCOPUS:36049010730

VL - 225

SP - 206

EP - 213

JO - Toxicology and Applied Pharmacology

JF - Toxicology and Applied Pharmacology

SN - 0041-008X

IS - 2

ER -